AVITA Medical annual gross margin
2018
2019
2020
2021
2022
2023
2024
2025
AVITA Medical's gross margin was 82.98% for fiscal 2025.
View full AVITA Medical company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 82.98% | −3.35 pp |
| 2024 | 2024-12-31 | 86.33% | +1.84 pp |
| 2023 | 2023-12-31 | 84.48% | +2.03 pp |
| 2022 | 2022-12-31 | 82.45% | +2.80 pp |
| 2021 | 2021-06-30 | 79.65% | +0.49 pp |
| 2020 | 2020-06-30 | 79.16% | +2.37 pp |
| 2019 | 2019-06-30 | 76.78% | +35.55 pp |
| 2018 | 2018-06-30 | 41.23% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 82.68% | +0.66 pp |
| Q1 2026 | 2026-03-31 | 82.50% | −3.07 pp |
| Q4 2025 | 2025-12-31 | 82.10% | −6.45 pp |
| Q3 2025 | 2025-09-30 | 82.12% | −2.22 pp |
| Q2 2025 | 2025-06-30 | 82.02% | −4.16 pp |
| Q1 2025 | 2025-03-31 | 85.57% | −0.80 pp |
| Q4 2024 | 2024-12-31 | 88.55% | +1.20 pp |
| Q3 2024 | 2024-09-30 | 84.34% | −0.18 pp |
| Q2 2024 | 2024-06-30 | 86.18% | +4.93 pp |
| Q1 2024 | 2024-03-31 | 86.37% | +2.18 pp |
| Q4 2023 | 2023-12-31 | 87.35% | +1.59 pp |
| Q3 2023 | 2023-09-30 | 84.51% | +1.34 pp |
| Q2 2023 | 2023-06-30 | 81.25% | −2.12 pp |
| Q1 2023 | 2023-03-31 | 84.20% | +7.78 pp |
| Q4 2022 | 2022-12-31 | 85.75% | +1.25 pp |
| Q3 2022 | 2022-09-30 | 83.17% | +3.10 pp |
| Q2 2022 | 2022-06-30 | 83.37% | +7.86 pp |
| Q1 2022 · Mar 31 | 2022-03-31 | 76.42% | −7.50 pp |
| Q1 2022 · Sep 30 | 2021-09-30 | 84.50% | +2.86 pp |
| Q4 2021 | 2021-06-30 | 80.08% | +2.62 pp |
| Q3 2021 | 2021-03-31 | 75.52% | −8.13 pp |
| Q2 2021 | 2020-12-31 | 83.91% | +9.87 pp |
| Q1 2021 | 2020-09-30 | 81.64% | +0.69 pp |
| Q4 2020 | 2020-06-30 | 77.46% | — |
| Q3 2020 | 2020-03-31 | 83.65% | — |
| Q2 2020 | 2019-12-31 | 74.04% | — |
| Q1 2020 | 2019-09-30 | 80.95% | — |
Over the last five reported fiscal years, AVITA Medical's gross margin increased from 79.16% to 82.98%, a change of +3.82 percentage points. The latest reported quarter, Q2 2026, shows 82.68%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AVITA Medical filings at SEC.gov ↗